Ritlecitinib

Molecular mass: 285.351 g/mol 

Therapeutic indications

Ritlecitinib is indicated for:

Alopecia areata

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Ritlecitinib is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Ritlecitinib is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

End-stage renal disease

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic impairment

Hepatic failure stage IV

Active serious infections, including tuberculosis

Infectious disease

Live vaccines

Live organism vaccines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: LITFULO Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈